Endocrinology, Vol 136, 5274-5282, Copyright © 1995 by Endocrine Society

ARTICLES

Conversion of angiotensin II into active fragments by an endosomal pathway in bovine adrenal medullary cells in primary culture

JM Wang, P Baudhuin, PJ Courtoy and W de Potter
Department of Medicine, University of Antwerp, Wilrijk, Belgium.

We previously demonstrated that angiotensin II (AII) is internalized in primary cultures of bovine adrenal medullary cells by receptor-mediated endocytosis. In the present work, we followed internalized AII in these cells by means of confocal laser scanning microscopy combined with analytical subcellular fractionation techniques and compared its fate with that of transferrin and horseradish peroxidase. The integrity of [125I]AII was investigated by chromatography. With pulse-chase experiments, internalized AII could only be detected in endosomes using either fluorescence microscopy or fractionation studies. With chase, most of the radioactivity initially associated with the cells was rapidly released into the medium, as converted fragments (> 60%), essentially as AIV (80% of the fragments). Fragments efficiently bound to bovine adrenal medullary and cortical cells, a binding that was specifically displaced by AIV > AIII = AII. These results indicate that AII is taken up in bovine adrenal medullary cells and can be rapidly converted in the endosomal pathway into fragments that bind specifically to putative angiotensin receptors. These fragments are presumably biologically active and could act on either the chromaffin cell itself (autocrine) or the cortical cells (paracrine).

This article has been cited by other articles:

				J. W Wright and J. W Harding The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 226 - 237. [Abstract] [PDF]

				J. J. Braszko, A. Walesiuk, and P. Wielgat Cognitive Effects Attributed to Angiotensin II may Result from its Conversion to Angiotensin IV Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 168 - 174. [Abstract] [PDF]

				J. M. Wang, S. J. Veerasingham, J. Tan, and F. H. H. Leenen Effects of high salt intake on brain AT1 receptor densities in Dahl rats Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1949 - H1955. [Abstract] [Full Text] [PDF]

				J. M. Wang, D. Slembrouck, J. Tan, L. Arckens, F. H. H. Leenen, P. J. Courtoy, and W. P. De Potter Presence of cellular renin-angiotensin system in chromaffin cells of bovine adrenal medulla Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1811 - H1818. [Abstract] [Full Text] [PDF]

				R. K. HANDA Metabolism Alters the Selectivity of Angiotensin-(1-7) Receptor Ligands for Angiotensin Receptors J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1377 - 1386. [Abstract] [Full Text]

				D Slembrouck, W. Annaert, J. Wang, and W. Potter Rab3 is present on endosomes from bovine chromaffin cells in primary culture J. Cell Sci., January 3, 1999; 112(5): 641 - 649. [Abstract] [PDF]

				N. Ishizaka, K. K. Griendling, B. Lassegue, and R. W. Alexander Angiotensin II Type 1 Receptor : Relationship With Caveolae and Caveolin After Initial Agonist Stimulation Hypertension, September 1, 1998; 32(3): 459 - 466. [Abstract] [Full Text] [PDF]